These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36875340)

  • 1.
    Umar AB; Uzairu A
    J Taibah Univ Med Sci; 2023 Oct; 18(5):933-946. PubMed ID: 36875340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New flavone-based arylamides as potential
    Umar AB; Uzairu A
    J Taibah Univ Med Sci; 2023 Oct; 18(5):1000-1010. PubMed ID: 36950455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
    Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dynamics, MMGBSA, and docking studies of natural products conjugated to tumor-targeted peptide for targeting BRAF V600E and MERTK receptors.
    Lambo DJ; Lebedenko CG; McCallum PA; Banerjee IA
    Mol Divers; 2023 Feb; 27(1):389-423. PubMed ID: 35505173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies.
    Bilal MS; Ejaz SA; Zargar S; Akhtar N; Wani TA; Riaz N; Aborode AT; Siddique F; Altwaijry N; Alkahtani HM; Umar HI
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer-aided identification of lead compounds as Staphylococcal epidermidis FtsZ inhibitors using molecular docking, virtual screening, DFT analysis, and molecular dynamic simulation.
    Tripathy S; Sahu SK; Azam MA; Jupudi S
    J Mol Model; 2019 Nov; 25(12):360. PubMed ID: 31773394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DFT, ADMET and Molecular Docking Investigations for the Antimicrobial Activity of 6,6'-Diamino-1,1',3,3'-tetramethyl-5,5'-(4-chlorobenzylidene)bis[pyrimidine-2,4(1H,3H)-dione].
    El-Shamy NT; Alkaoud AM; Hussein RK; Ibrahim MA; Alhamzani AG; Abou-Krisha MM
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, biological evaluation, and docking studies of novel (imidazol-5-yl)pyrimidine-based derivatives as dual BRAF
    Ali EMH; El-Telbany RFA; Abdel-Maksoud MS; Ammar UM; Mersal KI; Zaraei SO; El-Gamal MI; Choi SI; Lee KT; Kim HK; Lee KH; Oh CH
    Eur J Med Chem; 2021 Apr; 215():113277. PubMed ID: 33601311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of novel benzo-α-pyrone containing piperazine derivatives as potential BRAF
    Chen LW; Wang ZF; Zhu B; Man RJ; Liu YD; Zhang YH; Wang BZ; Wang ZC; Zhu HL
    Bioorg Med Chem Lett; 2016 Oct; 26(20):4983-4991. PubMed ID: 27634195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaussian field-based 3D-QSAR and molecular simulation studies to design potent pyrimidine-sulfonamide hybrids as selective BRAF
    Singh AK; Novak J; Kumar A; Singh H; Thareja S; Pathak P; Grishina M; Verma A; Yadav JP; Khalilullah H; Pathania V; Nandanwar H; Jaremko M; Emwas AH; Kumar P
    RSC Adv; 2022 Oct; 12(46):30181-30200. PubMed ID: 36329938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New pyrazolylindolin-2-one based coumarin derivatives as anti-melanoma agents: design, synthesis, dual BRAF
    Sabt A; Khedr MA; Eldehna WM; Elshamy AI; Abdelhameed MF; Allam RM; Batran RZ
    RSC Adv; 2024 Feb; 14(9):5907-5925. PubMed ID: 38370458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helix-Coil Transition Signatures B-Raf V600E Mutation and Virtual Screening for Inhibitors Directed Against Mutant B-Raf.
    Bandaru S; Sumithnath TG; Sharda S; Lakhotia S; Sharma A; Jain A; Hussain T; Nayarisseri A; Singh SK
    Curr Drug Metab; 2017 Jul; 18(6):527-534. PubMed ID: 28472910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docking simulation and ADMET prediction based investigation on the phytochemical constituents of Noni (
    Chandran K; Shane DI; Zochedh A; Sultan AB; Kathiresan T
    In Silico Pharmacol; 2022; 10(1):14. PubMed ID: 36034317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of potential inhibitors of
    Tewari D; Rawat K; Bisht A; Almoyad MAA; Wahab S; Chandra S; Pande V
    J Biomol Struct Dyn; 2024; 42(24):13953-13970. PubMed ID: 37922151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of pyrazole derivatives containing acetamide bond as potential BRAF
    Wang CR; Wang ZF; Shi L; Wang ZC; Zhu HL
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2382-2390. PubMed ID: 29934244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insight into molecular dynamics simulation of BRAF(V600E) and potent novel inhibitors for malignant melanoma.
    Tang HC; Chen YC
    Int J Nanomedicine; 2015; 10():3131-46. PubMed ID: 25960652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of novel imidazole derivatives possessing terminal sulphonamides as potential BRAF
    Ali EMH; Abdel-Maksoud MS; Ammar UM; Mersal KI; Ho Yoo K; Jooryeong P; Oh CH
    Bioorg Chem; 2021 Jan; 106():104508. PubMed ID: 33280830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DFT and
    Alsehli MH; Seth DS; El-Gaby MSA; Okasha RM; Hagar M; Afifi TH; Naqvi A
    Curr Org Synth; 2023; 20(5):523-545. PubMed ID: 36100991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular docking, drug-likeness and DFT study of some modified tetrahydrocurcumins as potential anticancer agents.
    Mahal A; Al-Janabi M; Eyüpoğlu V; Alkhouri A; Chtita S; Kadhim MM; Obaidullah AJ; Alotaibi JM; Wei X; Pratama MRF
    Saudi Pharm J; 2024 Jan; 32(1):101889. PubMed ID: 38090737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.